Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease

References

• Galor A, Feuer W, Lee DJ, et al. Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population. Am J Ophthalmol. 2011;152:377–384 e372
   PubMed Web of Science ®Google Scholar
• Thelin WR, Johnson MR, Hirsh AJ, et al. Effect of topically applied epithelial sodium channel inhibitors on tear production in normal mice and in mice with induced aqueous tear deficiency. J Ocul Pharmacol Ther. 2012;28:433–438
   PubMed Web of Science ®Google Scholar
• Zoukhri D. Mechanisms involved in injury and repair of the murine lacrimal gland: role of programmed cell death and mesenchymal stem cells. Ocul Surf. 2010;8:60–69
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol. 2009;127:763–768
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318–326
   PubMed Web of Science ®Google Scholar
• Yu J, Asche CV, Fairchild CJ. The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea. 2011;30:379–387
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Yamada M, Miyake Y. Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome. Jpn J Ophthalmol. 2010;54:259–265
   PubMed Web of Science ®Google Scholar
• Reddy P, Grad O, Rajagopalan K. The economic burden of dry eye: a conceptual framework and preliminary assessment. Cornea. 2004;23:751–761
   PubMed Web of Science ®Google Scholar
• Zoukhri D. Effect of inflammation on lacrimal gland function. Exp Eye Res. 2006;82:885–898
   PubMed Web of Science ®Google Scholar
• Zoukhri D, Hodges RR, Dartt DA. Lacrimal gland innervation is not altered with the onset and progression of disease in a murine model of Sjögren's syndrome. Clin Immunol Immunopathol. 1998;89:126–133
   PubMedGoogle Scholar
• Zoukhri D, Macari E, Choi SH, Kublin CL. c-Jun NH2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretion. J Neurochem. 2006;96:126–135
   PubMed Web of Science ®Google Scholar
• Zoukhri D, Macari E, Kublin CL. A single injection of interleukin-1 induces reversible aqueous-tear deficiency, lacrimal gland inflammation, and acinar and ductal cell proliferation. Exp Eye Res. 2007;84:894–904
   PubMed Web of Science ®Google Scholar
• Paiva CS, Pflugfelder SC. Rationale for anti-inflammatory therapy in dry eye syndrome. Arq Bras Oftalmol. 2008;71:89–95
   PubMed Web of Science ®Google Scholar
• DeVoss JJ, LeClair NP, Hou Y, et al. An autoimmune response to odorant binding protein 1a is associated with dry eye in the Aire-deficient mouse. J Immunol. 2010;184:4236–4246
   PubMed Web of Science ®Google Scholar
• Knop N, Knop E. Regulation of the inflammatory component in chronic dry eye disease by the eye-associated lymphoid tissue (EALT). Dev Ophthalmol. 2010;45:23–39
   PubMedGoogle Scholar
• Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012;31:271–285
   PubMed Web of Science ®Google Scholar
• Redfern RL, Patel N, Hanlon S, et al. Toll-like receptor expression and activation in mice with experimental dry eye. Invest Ophthalmol Vis Sci. 2013;54:1554–1563
   PubMed Web of Science ®Google Scholar
• Narayanan S, Redfern RL, Miller WL, et al. Dry eye disease and microbial keratitis: is there a connection? Ocul Surf. 2013;11:75–92
   PubMed Web of Science ®Google Scholar
• McDermott AM. New insight into dry eye inflammation. Invest Ophthalmol Vis Sci. 2012;53--72:8264
   Web of Science ®Google Scholar
• Kolar SS, McDermott AM. Role of host-defence peptides in eye diseases. Cell Mol Life Sci. 2011;68:2201–2213
   PubMed Web of Science ®Google Scholar
• Redfern RL, McDermott AM. Toll-like receptors in ocular surface disease. Exp Eye Res. 2010;90:679–687
   PubMed Web of Science ®Google Scholar
• Liu Q, McDermott AM, Miller WL. Elevated nerve growth factor in dry eye associated with established contact lens wear. Eye Contact Lens. 2009;35:232–237
   PubMed Web of Science ®Google Scholar
• Tomlinson A, Giesbrecht C. Effect of age on human tear film evaporation in normals. Adv Exp Med Biol. 1994;350:271–274
   PubMedGoogle Scholar
• Tsubota K, Yamada M. Tear evaporation from the ocular surface. Invest Ophthalmol Vis Sci. 1992;33:2942–2950
   PubMed Web of Science ®Google Scholar
• Borchman D, Foulks GN, Yappert MC, et al. Factors affecting evaporation rates of tear film components measured in vitro. Eye Contact Lens. 2009;35:32–37
   PubMed Web of Science ®Google Scholar
• Guillon M, Maissa C. Tear film evaporation—effect of age and gender. Cont Lens Anterior Eye. 2010;33:171–175
   PubMed Web of Science ®Google Scholar
• Klein R, Myers CE, Cruickshanks KJ, et al. Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study. JAMA Ophthalmol. 2014;132:446–455
   PubMed Web of Science ®Google Scholar
• Rodrigues EB. Inflammation in dry age-related macular degeneration. Ophthalmologica. 2007;221:143–152
   PubMed Web of Science ®Google Scholar
• Cevenini E, Caruso C, Candore G, et al. Age-related inflammation: the contribution of different organs, tissues and systems: how to face it for therapeutic approaches. Curr Pharm Des. 2010;16:609–618
   PubMed Web of Science ®Google Scholar
• Magrone T, Jirillo E. The interaction between gut microbiota and age-related changes in immune function and inflammation. Immun Ageing. 2013;10:31
   PubMed Web of Science ®Google Scholar
• Rehman T. Role of the gut microbiota in age-related chronic inflammation. Endocr Metab Immune Disord Drug Targets. 2012;12:361–367
   PubMedGoogle Scholar
• Konttinen YT, Fuellen G, Bing Y, et al. Sex steroids in Sjögren's syndrome. J Autoimmun. 2012;39:49–56
   PubMed Web of Science ®Google Scholar
• Porola P, Laine M, Virkki L, et al. The influence of sex steroids on Sjögren's syndrome. Ann N Y Acad Sci. 2007;1108:426–432
   PubMed Web of Science ®Google Scholar
• Di Tommaso C, Valamanesh F, Miller F, et al. A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation. Invest Ophthalmol Vis Sci. 2012;53:2292–2299
   PubMed Web of Science ®Google Scholar
• Di Tommaso C, Bourges JL, Valamanesh F, et al. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies. Eur J Pharm Biopharm. 2012;81:257–264
   PubMed Web of Science ®Google Scholar
• Di Tommaso C, Torriglia A, Furrer P, et al. Ocular biocompatibility of novel cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers. Int J Pharm. 2011;416:515–524
   PubMed Web of Science ®Google Scholar
• Di Tommaso C, Behar-Cohen F, Gurny R, Moller M. Colloidal systems for the delivery of cyclosporin A to the anterior segment of the eye. Ann Pharm Fr. 2011;69:116–123
   PubMedGoogle Scholar
• Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012;130:90–100
   PubMed Web of Science ®Google Scholar
• Galor A, Feuer W, Lee DJ, et al. Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database. Am J Ophthalmol. 2012;154:340–346 e342
   PubMed Web of Science ®Google Scholar
• Pouyeh B, Viteri E, Feuer W, et al. Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Am J Ophthalmol. 2012;153:1061–1066, e1063
   PubMed Web of Science ®Google Scholar
• Galor A, Feuer W, Lee DJ, et al. Ocular surface parameters in older male veterans. Invest Ophthalmol Vis Sci. 2013;54:1426–1433
   PubMed Web of Science ®Google Scholar
• Mircheff AK, Wang Y, Thomas PB, et al. Systematic variations in immune response-related gene transcript abundance suggest new questions about environmental influences on lacrimal gland immunoregulation. Curr Eye Res. 2011;36:285–294
   PubMed Web of Science ®Google Scholar
• Schechter JE, Warren DW, Mircheff AK. A lacrimal gland is a lacrimal gland, but rodent's and rabbit's are not human. Ocul Surf. 2010;8:111–134
   PubMed Web of Science ®Google Scholar
• Trousdale MD, Stevenson D, Zhu Z, et al. Effect of anti-inflammatory cytokines on the activation of lymphocytes by lacrimal gland acinar cells in an autologous mixed cell reaction. Adv Exp Med Biol. 2002;506:789–794
   PubMed Web of Science ®Google Scholar
• The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:75–92
   Google Scholar
• De Paiva CS, Hwang CS, Pitcher JD III, et al. Age-related T-cell cytokine profile parallels corneal disease severity in Sjögren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford). 2010;49:246–258
   PubMed Web of Science ®Google Scholar
• De Paiva CS, Volpe EA, Gandhi NB, et al. Disruption of TGF-beta signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca. PLoS One. 2011;6:e29017
   PubMed Web of Science ®Google Scholar
• Gumus K, Cavanagh DH. The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca. Clin Ophthalmol. 2009;3:57–67
   PubMedGoogle Scholar
• Jiang G, Ke Y, Sun D, et al. A new model of experimental autoimmune keratoconjunctivitis sicca (KCS) induced in Lewis rat by the autoantigen Klk1b22. Invest Ophthalmol Vis Sci. 2009;50:2245–2254
   PubMed Web of Science ®Google Scholar
• Na KS, Mok JW, Kim JY, et al. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest Ophthalmol Vis Sci. 2012;53:5443–5450
   PubMed Web of Science ®Google Scholar
• Lee SY, Han SJ, Nam SM, et al. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients. Am J Ophthalmol. 2013;156:247–253 e241
   PubMed Web of Science ®Google Scholar
• Massingale ML, Li X, Vallabhajosyula M, et al. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009;28:1023–1027
   PubMed Web of Science ®Google Scholar
• Alunno A, Petrillo MG, Nocentini G, et al. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome. Rheumatology (Oxford). 2013;52:1387–1396
   PubMed Web of Science ®Google Scholar
• Bianchini R, Bistoni O, Alunno A, et al. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity. Eur J Immunol. 2011;41:2269–2278
   PubMed Web of Science ®Google Scholar
• Alunno A, Nocentini G, Bistoni O, et al. Expansion of CD4+CD25–GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity. Reumatismo. 2012;64:293–298
   PubMedGoogle Scholar
• Prakash S, Agrawal S, Siraj H, et al. Dendritic cells from aged subjects contribute to chronic airway inflammation by activating bronchial epithelial cells under steady state. Mucosal Immunol. 2014;in press:1–14
   Google Scholar
• Ullrich SE. Two-way traffic on the bridge from innate to adaptive immunity. J Invest Dermatol. 2010;130:1773–1775
   PubMed Web of Science ®Google Scholar
• Ank N, Paludan SR. Type III IFNs: new layers of complexity in innate antiviral immunity. Biofactors. 2009;35:82–87
   PubMed Web of Science ®Google Scholar
• Martin LD, Rochelle LG, Fischer BM, et al. Airway epithelium as an effector of inflammation: molecular regulation of secondary mediators. Eur Respir J. 1997;10:2139–2146
   PubMed Web of Science ®Google Scholar
• Skalicky SE, Petsoglou C, Gurbaxani A, et al. New agents for treating dry eye syndrome. Curr Allergy Asthma Rep. 2013;13:322–328
   PubMed Web of Science ®Google Scholar
• McCann LC, Tomlinson A, Pearce EI, Papa V. Effectiveness of artificial tears in the management of evaporative dry eye. Cornea. 2012;31:1–5
   PubMed Web of Science ®Google Scholar
• Rolando M, Barabino S, Mingari C, et al. Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes. Cornea. 2005;24:951–954
   PubMed Web of Science ®Google Scholar
• Uchino M, Schaumberg DA. Dry eye disease: impact on quality of life and vision. Curr Ophthalmol Rep. 2013;1:51–57
   PubMedGoogle Scholar
• Li M, Gong L, Chapin WJ, Zhu M. Assessment of vision-related quality of life in dry eye patients. Invest Ophthalmol Vis Sci. 2012;53:5722–5727
   PubMed Web of Science ®Google Scholar
• Denoyer A, Rabut G, Baudouin C. Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease. Ophthalmology. 2012;119:1811–1818
   PubMed Web of Science ®Google Scholar
• Borrelli E, Diadori A, Zalaffi A, Bocci V. Effects of major ozonated autohemotherapy in the treatment of dry age related macular degeneration: a randomized controlled clinical study. Int J Ophthalmol. 2012;5:708–713
   PubMed Web of Science ®Google Scholar
• Larose J, Boulay P, Wright-Beatty HE, et al. Age-related differences in heat loss capacity occur under both dry and humid heat stress conditions. J Appl Physiol. (1985) 2014;117:69–79
   PubMed Web of Science ®Google Scholar
• Schafer G, Hoffmann W, Berry M, Paulsen F. Lacrimal gland-associated mucins: age related production and their role in the pathophysiology of dry eye. Ophthalmologe. 2005;102:175–183
   PubMed Web of Science ®Google Scholar
• Dana MR, Hamrah P. Role of immunity and inflammation in corneal and ocular surface disease associated with dry eye. Adv Exp Med Biol. 2002;506:729–738
   PubMed Web of Science ®Google Scholar
• Jarka ES, Kahrhoff M, Crane JB. Dry-eye—is inflammation just the tip of the iceberg? Optometry. 2012;83:111–113
   PubMedGoogle Scholar
• Stern ME, Pflugfelder SC. Inflammation in dry eye. Ocul Surf. 2004;2:124–130
   PubMedGoogle Scholar
• Stern ME, Siemasko KF, Gao J, et al. Evaluation of ocular surface inflammation in the presence of dry eye and allergic conjunctival disease. Ocul Surf. 2005;3:S161–S164
   PubMed Web of Science ®Google Scholar
• Wilson SE. Inflammation: a unifying theory for the origin of dry eye syndrome. Manag Care. 2003;12:14–19
   PubMedGoogle Scholar
• Agrawal A, Gupta S. Impact of aging on dendritic cell functions in humans. Ageing Res Rev. 2011;10:336–345
   PubMed Web of Science ®Google Scholar
• Agrawal A, Agrawal S, Gupta S. Dendritic cells in human aging. Exp Gerontol. 2007;42:421–426
   PubMed Web of Science ®Google Scholar
• Sridharan A, Esposo M, Kaushal K, et al. Age-associated impaired plasmacytoid dendritic cell functions lead to decreased CD4 and CD8 T cell immunity. Age (Dordr). 2011;33:363–376
   PubMed Web of Science ®Google Scholar
• Williams GP, Tomlins PJ, Denniston AK, et al. Elevation of conjunctival epithelial CD45INTCD11b(+)CD16(+)CD14(−) neutrophils in ocular Stevens-Johnson syndrome and toxic epidermal necrolysis. Invest Ophthalmol Vis Sci. 2013;54:4578–4585
   PubMed Web of Science ®Google Scholar
• Williams GP, Denniston AK, Oswal KS, et al. The dominant human conjunctival epithelial CD8alphabeta+ T cell population is maintained with age but the number of CD4+ T cells increases. Age (Dordr). 2012;34:1517–1528
   PubMed Web of Science ®Google Scholar
• Saito T, Nishida K, Sugiyama H, et al. Abnormal keratocytes and stromal inflammation in chronic phase of severe ocular surface diseases with stem cell deficiency. Br J Ophthalmol. 2008;92:404–410
   PubMed Web of Science ®Google Scholar
• Polisetty N, Fatima A, Madhira SL, et al. Mesenchymal cells from limbal stroma of human eye. Mol Vis. 2008;14:431–442
   PubMed Web of Science ®Google Scholar
• Yang P, Das PK, Kijlstra A. Localization and characterization of immunocompetent cells in the human retina. Ocul Immunol Inflamm. 2000;8:149–157
   PubMed Web of Science ®Google Scholar
• Chentoufi AA, Dasgupta G, Nesburn AB, et al. Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization. Clin Vaccine Immunol. 2010;17:342–353
   PubMed Web of Science ®Google Scholar
• Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69:S4–S9
   PubMed Web of Science ®Google Scholar
• Goto M. Inflammaging (inflammation + aging): a driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? Biosci Trends. 2008;2:218–230
   PubMed Web of Science ®Google Scholar
• Navarrete-Reyes AP, Montana-Alvarez M. Inflammaging: aging inflammatory origin. Rev Invest Clin. 2009;61:327–336
   PubMed Web of Science ®Google Scholar
• Chauhan SK, El Annan J, Ecoiffier T, et al. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol. 2009;182:1247–1252
   PubMed Web of Science ®Google Scholar
• Coursey TG, Gandhi NB, Volpe EA, et al. Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease. PLoS One. 2013;8:e78508
   PubMed Web of Science ®Google Scholar
• Dohlman TH, Chauhan SK, Kodati S, et al. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. Invest Ophthalmol Vis Sci. 2013;54:4081–4091
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Corrales RM, de Paiva CS. T helper cytokines in dry eye disease. Exp Eye Res. 2013;117:118–125
   PubMed Web of Science ®Google Scholar
• Turpie B, Yoshimura T, Gulati A, et al. Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice. Am J Pathol. 2009;175:1136–1147
   PubMed Web of Science ®Google Scholar
• Nesburn AB, Bettahi I, Zhang X, et al. Topical/mucosal delivery of sub-unit vaccines that stimulate the ocular mucosal immune system. Ocul Surf. 2006;4:178–187
   PubMed Web of Science ®Google Scholar
• Wohlfert EA, Grainger JR, Bouladoux N, et al. GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice. J Clin Invest. 2011;121:4503–4515
   PubMed Web of Science ®Google Scholar
• Nesburn AB, Bettahi I, Dasgupta G, et al. Functional Foxp3+ CD4+ CD25(Bright+) “natural” regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection. J Virol. 2007;81:7647–7661
   PubMed Web of Science ®Google Scholar
• Siemasko KF, Gao J, Calder VL, et al. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. Invest Ophthalmol Vis Sci. 2008;49:5434–5440
   PubMed Web of Science ®Google Scholar
• Chentoufi AA, Dasgupta G, Christensen ND, et al. A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes. J Immunol. 2010;184:2561–2571
   PubMed Web of Science ®Google Scholar
• Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:179–193
   Google Scholar
• Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:163–178
   Google Scholar
• Chen Y, Chauhan SK, Lee HS, et al. Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis. Invest Ophthalmol Vis Sci. 2013;54:2457–2464
   PubMed Web of Science ®Google Scholar
• Fabiani C, Barabino S, Rashid S, Dana MR. Corneal epithelial proliferation and thickness in a mouse model of dry eye. Exp Eye Res. 2009;89:166–171
   PubMed Web of Science ®Google Scholar
• Goyal S, Chauhan SK, El Annan J, et al. Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? Arch Ophthalmol. 2010;128:819–824
   PubMed Web of Science ®Google Scholar
• Lee HS, Hattori T, Park EY, et al. Expression of Toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease. Invest Ophthalmol Vis Sci. 2012;53:5632–5640
   PubMed Web of Science ®Google Scholar
• Vijmasi T, Chen FY, Chen YT, et al. Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease. Mol Vis. 2013;19:1957–1965
   PubMed Web of Science ®Google Scholar
• Barabino S, Dana MR. Dry eye syndromes. Chem Immunol Allergy. 2007;92:176–184
   PubMedGoogle Scholar
• Gao J, Morgan G, Tieu D, et al. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice. Exp Eye Res. 2004;78:823–835
   PubMed Web of Science ®Google Scholar
• Brignole F, Pisella PJ, Goldschild M, et al. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000;41:1356–1363
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC. Differential diagnosis of dry eye conditions. Adv Dent Res. 1996;10:9–12
   PubMedGoogle Scholar
• Nguyen CQ, Gao JH, Kim H, et al. IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse. J Immunol. 2007;179:382–390
   PubMed Web of Science ®Google Scholar
• Nguyen CQ, Kim H, Cornelius JG, Peck AB. Development of Sjögren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3. J Immunol. 2007;179:2318–2329
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Arakaki R, Ishimaru N. The role of caspase cascade on the development of primary Sjögren's syndrome. J Med Invest. 2003;50:32–38
   PubMedGoogle Scholar
• Manganelli P, Fietta P. Apoptosis and Sjögren syndrome. Semin Arthritis Rheum. 2003;33:49–65
   PubMed Web of Science ®Google Scholar
• Nguyen CQ, Cornelius JG, Cooper L, et al. Identification of possible candidate genes regulating Sjögren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy. Arthritis Res Ther. 2008;10:R137
   PubMed Web of Science ®Google Scholar
• Wildenberg ME, Welzen-Coppens JM, van Helden-Meeuwsen CG, et al. Increased frequency of CD16+ monocytes and the presence of activated dendritic cells in salivary glands in primary Sjögren syndrome. Ann Rheum Dis. 2009;68:420–426
   PubMed Web of Science ®Google Scholar
• Chen YT, Li S, Nikulina K, et al. Immune profile of squamous metaplasia development in autoimmune regulator-deficient dry eye. Mol Vis. 2009;15:563–576
   PubMed Web of Science ®Google Scholar
• Marko CK, Menon BB, Chen G, et al. Spdef null mice lack conjunctival goblet cells and provide a model of dry eye. Am J Pathol. 2013;183:35–48
   PubMed Web of Science ®Google Scholar
• Xu J, Wang D, Liu D, et al. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome. Blood. 2012;120:3142–3151
   PubMed Web of Science ®Google Scholar
• Sullivan DA, Krenzer KL, Sullivan BD, et al. Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency? Invest Ophthalmol Vis Sci. 1999;40:1261–1265
   PubMed Web of Science ®Google Scholar
• Sullivan DA, Sullivan BD, Evans JE, et al. Androgen deficiency, meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci. 2002;966:211–222
   PubMed Web of Science ®Google Scholar
• Suhalim JL, Parfitt GJ, Xie Y, et al. Effect of desiccating stress on mouse meibomian gland function. Ocul Surf. 2014;12:59–68
   PubMed Web of Science ®Google Scholar
• Parfitt GJ, Xie Y, Geyfman M, et al. Absence of ductal hyper-keratinization in mouse age-related meibomian gland dysfunction (ARMGD). Aging (Albany NY). 2013;5:825–834
   PubMedGoogle Scholar
• Nien CJ, Massei S, Lin G, et al. Effects of age and dysfunction on human meibomian glands. Arch Ophthalmol. 2011;129:462–469
   PubMed Web of Science ®Google Scholar
• Nien CJ, Flynn KJ, Chang M, et al. Reducing peak corneal haze after photorefractive keratectomy in rabbits: prednisolone acetate 1.00% versus cyclosporine A 0.05%. J Cataract Refract Surg. 2011;37:937–944
   PubMed Web of Science ®Google Scholar
• Fujihara T, Nagano T, Nakamura M, Shirasawa E. Lactoferrin suppresses loss of corneal epithelial integrity in a rabbit short-term dry eye model. J Ocul Pharmacol Ther. 1998;14:99–107
   PubMed Web of Science ®Google Scholar
• Fujihara T, Nagano T, Nakamura M, Shirasawa E. Establishment of a rabbit short-term dry eye model. J Ocul Pharmacol Ther. 1995;11:503–508
   PubMed Web of Science ®Google Scholar
• Zhou L, Wei R, Zhao P, et al. Proteomic analysis revealed the altered tear protein profile in a rabbit model of Sjögren's syndrome-associated dry eye. Proteomics. 2013;13:2469–2481
   PubMed Web of Science ®Google Scholar
• Toshida H, Ohta T, Suto C, Murakami A. Effect of subconjunctival lacrimal gland transplantation in a rabbit dry eye model. Cornea. 2013;32:S46–S51
   PubMed Web of Science ®Google Scholar
• Li C, Song Y, Luan S, et al. Research on the stability of a rabbit dry eye model induced by topical application of the preservative benzalkonium chloride. PLoS One. 2012;7:e33688
   PubMed Web of Science ®Google Scholar
• Toshida H, Nguyen DH, Beuerman RW, Murakami A. Neurologic evaluation of acute lacrimomimetic effect of cyclosporine in an experimental rabbit dry eye model. Invest Ophthalmol Vis Sci. 2009;50:2736–2741
   PubMed Web of Science ®Google Scholar
• Xiong C, Chen D, Liu J, et al. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride. Invest Ophthalmol Vis Sci. 2008;49:1850–1856
   PubMed Web of Science ®Google Scholar
• Toshida H, Nguyen DH, Beuerman RW, Murakami A. Evaluation of novel dry eye model: preganglionic parasympathetic denervation in rabbit. Invest Ophthalmol Vis Sci. 2007;48:4468–4475
   PubMed Web of Science ®Google Scholar
• Oh JY, In YS, Kim MK, et al. Protective effect of uridine on cornea in a rabbit dry eye model. Invest Ophthalmol Vis Sci. 2007;48:1102–1109
   PubMed Web of Science ®Google Scholar
• Beutel J, Schroder C, von Hof K, et al. Pharmacological prevention of radiation-induced dry eye—an experimental study in a rabbit model. Graefes Arch Clin Exp Ophthalmol. 2007;245:1347–1355
   PubMed Web of Science ®Google Scholar
• Altinors DD, Bozbeyoglu S, Karabay G, Akova YA. Evaluation of ocular surface changes in a rabbit dry eye model using a modified impression cytology technique. Curr Eye Res. 2007;32:301–307
   PubMed Web of Science ®Google Scholar
• Nagelhout TJ, Gamache DA, Roberts L, et al. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye. J Ocul Pharmacol Ther. 2005;21:139–148
   PubMed Web of Science ®Google Scholar
• Gamache DA, Wei ZY, Weimer LK, et al. Preservation of corneal integrity by the mucin secretagogue 15(S)-HETE in a rabbit model of desiccation-induced dry eye. Adv Exp Med Biol. 2002;506:335–340
   PubMed Web of Science ®Google Scholar
• Fujihara T, Murakami T, Nagano T, et al. INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model. J Ocul Pharmacol Ther. 2002;18:363–370
   PubMed Web of Science ®Google Scholar
• Burgalassi S, Panichi L, Chetoni P, et al. Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes. Ophthalmic Res. 1999;31:229–235
   PubMed Web of Science ®Google Scholar
• Ding J, Sullivan DA. Aging and dry eye disease. Exp Gerontol. 2012;47:483–490
   PubMed Web of Science ®Google Scholar
• Gilbard JP, Rossi SR, Azar DT, Heyda KG. Effect of punctal occlusion by Freeman silicone plug insertion on tear osmolarity in dry eye disorders. CLAO J. 1989;15:216–218
   PubMedGoogle Scholar
• Barabino S, Shen L, Chen L, et al. The controlled–environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci. 2005;46:2766–2771
   PubMed Web of Science ®Google Scholar
• Gonzalez-Garcia MJ, Gonzalez-Saiz A, de la Fuente B, et al. Exposure to a controlled adverse environment impairs the ocular surface of subjects with minimally symptomatic dry eye. Invest Ophthalmol Vis Sci. 2007;48:4026–4032
   PubMed Web of Science ®Google Scholar
• Lopez-Miguel A, Teson M, Martin-Montanez V, et al. Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions. Am J Ophthalmol. 2014;157:788–798 e782
   PubMed Web of Science ®Google Scholar
• Madden LC, Tomlinson A, Simmons PA. Effect of humidity variations in a controlled environment chamber on tear evaporation after dry eye therapy. Eye Contact Lens. 2013;39:169–174
   PubMed Web of Science ®Google Scholar
• Singh G, Bhinder HS. Closed chamber thermometry and humidity measurements in normal and dry eye patients: a pilot study. Eur J Ophthalmol. 2003;13:343–350
   PubMed Web of Science ®Google Scholar
• Steagall RJ, Yamagami H, Wickham LA, Sullivan DA. Androgen control of gene expression in the rabbit meibomian gland. Adv Exp Med Biol. 2002;506:465–476
   PubMed Web of Science ®Google Scholar
• Frame NJ, Burkat CN. Identifying an appropriate animal model for the nasolacrimal drainage system. Ophthal Plast Reconstr Surg. 2009;25:354–358
   PubMed Web of Science ®Google Scholar
• Bergmanson JP, Doughty MJ, Blocker Y. The acinar and ductal organisation of the tarsal accessory lacrimal gland of Wolfring in rabbit eyelid. Exp Eye Res. 1999;68:411–421
   PubMed Web of Science ®Google Scholar
• Wood RL, Mircheff AK. Apical and basal-lateral Na/K-ATPase in rat lacrimal gland acinar cells. Invest Ophthalmol Vis Sci. 1986;27:1293–1296
   PubMed Web of Science ®Google Scholar
• Wood RL, Park KH, Gierow JP, Mircheff AK. Immunogold localization of prolactin in acinar cells of lacrimal gland. Adv Exp Med Biol. 1994;350:75–77
   PubMedGoogle Scholar
• Wood RL, Trousdale MD, Stevenson D, et al. Adenovirus infection of the cornea causes histopathologic changes in the lacrimal gland. Curr Eye Res. 1997;16:459–466
   PubMed Web of Science ®Google Scholar
• Wood RL, Zhang J, Huang ZM, et al. Prolactin and prolactin receptors in the lacrimal gland. Exp Eye Res. 1999;69:213–226
   PubMed Web of Science ®Google Scholar
• Thomas PB, Samant DM, Selvam S, et al. Adeno-associated virus-mediated IL-10 gene transfer suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis. Invest Ophthalmol Vis Sci. 2010;51:5137–5144
   PubMed Web of Science ®Google Scholar
• Hodges RR, Dartt DA. Regulatory pathways in lacrimal gland epithelium. Int Rev Cytol. 2003;231:129–196
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Tsuzaka K, Takeuchi T, et al. Altered distribution of aquaporin 5 and its C-terminal binding protein in the lacrimal glands of a mouse model for Sjögren's syndrome. Curr Eye Res. 2008;33:621–629
   PubMed Web of Science ®Google Scholar
• Ding C, Chang N, Fong YC, et al. Interacting influences of pregnancy and corneal injury on rabbit lacrimal gland immunoarchitecture and function. Invest Ophthalmol Vis Sci. 2006;47:1368–1375
   PubMed Web of Science ®Google Scholar
• McClellan KA, Robertson FG, Kindblom J, et al. Investigation of the role of prolactin in the development and function of the lacrimal and harderian glands using genetically modified mice. Invest Ophthalmol Vis Sci. 2001;42:23–30
   PubMed Web of Science ®Google Scholar
• Botelho SY. Tears and the lacrimal gland. Sci Am 1964;211:78–86
   PubMed Web of Science ®Google Scholar
• Dartt DA. Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases. Prog Retin Eye Res. 2009;28:155–177
   PubMed Web of Science ®Google Scholar
• Janowsky DS, Drennan M, Berkowitz A, et al. Comparative effects of scopolamine and atropine in preventing cholinesterase inhibitor induced lethality. Mil Med. 1985;150:693–695
   PubMed Web of Science ®Google Scholar
• Thiermann H, Radtke M, Spohrer U, et al. Pharmacokinetics of atropine in dogs after i.m. injection with newly developed dry/wet combination autoinjectors containing HI 6 or HLo 7. Arch Toxicol. 1996;70:293–299
   PubMed Web of Science ®Google Scholar
• Salminen L. Review: systemic absorption of topically applied ocular drugs in humans. J Ocul Pharmacol. 1990;6:243–249
   PubMedGoogle Scholar
• Odaka A, Toshida H, Ohta T, et al. Efficacy of retinol palmitate eye drops for dry eye in rabbits with lacrimal gland resection. Clin Ophthalmol. 2012;6:1585–1593
   PubMedGoogle Scholar
• Thomas PB, Samant DM, Zhu Z, et al. Long-term topical cyclosporine treatment improves tear production and reduces keratoconjunctivitis in rabbits with induced autoimmune dacryoadenitis. J Ocul Pharmacol Ther. 2009;25:285–292
   PubMed Web of Science ®Google Scholar
• Trousdale MD, Zhu Z, Stevenson D, et al. Expression of TNF inhibitor gene in the lacrimal gland promotes recovery of tear production and tear stability and reduced immunopathology in rabbits with induced autoimmune dacryoadenitis. J Autoimmune Dis. 2005;2:6
   PubMedGoogle Scholar
• Oprea L, Tiberghien A, Creuzot-Garcher C, Baudouin C. Hormonal regulatory influence in tear film. J Fr Ophtalmol. 2004;27:933–941
   PubMed Web of Science ®Google Scholar
• Zhu Z, Stevenson D, Schechter JE, et al. Lacrimal histopathology and ocular surface disease in a rabbit model of autoimmune dacryoadenitis. Cornea. 2003;22:25–32
   PubMed Web of Science ®Google Scholar
• Paulsen F. The human nasolacrimal ducts. Adv Anat Embryol Cell Biol. 2003;170:III–XI, 1–106
   PubMed Web of Science ®Google Scholar
• Schonthal AH, Warren DW, Stevenson D, et al. Proliferation of lacrimal gland acinar cells in primary culture: stimulation by extracellular matrix, EGF, and DHT. Exp Eye Res. 2000;70:639–649
   PubMed Web of Science ®Google Scholar
• Guo Z, Song D, Azzarolo AM, et al. Autologous lacrimal-lymphoid mixed-cell reactions induce dacryoadenitis in rabbits. Exp Eye Res. 2000;71:23–31
   PubMed Web of Science ®Google Scholar
• Romanowski EG, Gordon YJ, Araullo-Cruz T, et al. The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand White rabbit ocular model. Invest Ophthalmol Vis Sci. 2001;42:1812–1815
   PubMed Web of Science ®Google Scholar
• Nesburn AB, Ramos TV, Zhu X, et al. Local and systemic B cell and Th1 responses induced following ocular mucosal delivery of multiple epitopes of herpes simplex virus type 1 glycoprotein D together with cytosine-phosphate-guanine adjuvant. Vaccine. 2005;23:873–883
   PubMed Web of Science ®Google Scholar
• Trousdale MD, Dunkel EC, Nesburn AB. Effect of flurbiprofen on herpes simplex keratitis in rabbits. Invest Ophthalmol Vis Sci. 1980;19:267–270
   PubMed Web of Science ®Google Scholar
• Knop E, Knop N. The role of eye-associated lymphoid tissue in corneal immune protection. J Anat. 2005;206:271–285
   PubMed Web of Science ®Google Scholar
• Knop N, Knop E. Ultrastructural anatomy of CALT follicles in the rabbit reveals characteristics of M-cells, germinal centres and high endothelial venules. J Anat. 2005;207:409–426
   PubMed Web of Science ®Google Scholar
• Liang H, Baudouin C, Daull P, et al. Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model. Mol Vis. 2012;18:2195–2204
   PubMed Web of Science ®Google Scholar
• Liang H, Baudouin C, Dupas B, Brignole-Baudouin F. Live conjunctiva-associated lymphoid tissue analysis in rabbit under inflammatory stimuli using in vivo confocal microscopy. Invest Ophthalmol Vis Sci. 2010;51:1008–1015
   PubMed Web of Science ®Google Scholar
• Liu H, Meagher CK, Moore CP, Phillips TE. M cells in the follicle-associated epithelium of the rabbit conjunctiva preferentially bind and translocate latex beads. Invest Ophthalmol Vis Sci. 2005;46:4217–4223
   PubMed Web of Science ®Google Scholar
• Dasgupta G, Chentoufi AA, You S, et al. Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25− effector T cell responses. Invest Ophthalmol Vis Sci. 2011;52:3321–3333
   PubMed Web of Science ®Google Scholar
• Lanning D, Sethupathi P, Rhee KJ, et al. Intestinal microflora and diversification of the rabbit antibody repertoire. J Immunol. 2000;165:2012–2019
   PubMed Web of Science ®Google Scholar
• McDonald ML, Wang Y, Selvam S, et al. Cytopathology and exocrine dysfunction induced in ex vivo rabbit lacrimal gland acinar cell models by chronic exposure to histamine or serotonin. Invest Ophthalmol Vis Sci. 2009;50:3164–3175
   PubMed Web of Science ®Google Scholar
• Li N, Deng X, Gao Y, et al. Establishment of the mild, moderate and severe dry eye models using three methods in rabbits. BMC Ophthalmol. 2013;13:50
   PubMed Web of Science ®Google Scholar
• Narayanan S, Miller WL, McDermott AM. Conjunctival cytokine expression in symptomatic moderate dry eye subjects. Invest Ophthalmol Vis Sci. 2006;47:2445–2450
   PubMed Web of Science ®Google Scholar
• Zhao C, Cai Y, He X, et al. Synthesis and anti-inflammatory evaluation of novel mono-carbonyl analogues of curcumin in LPS-stimulated RAW 264.7 macrophages. Eur J Med Chem. 2010;45:5773–5780
   PubMed Web of Science ®Google Scholar
• Bereswill S, Munoz M, Fischer A, et al. Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One. 2010;5:e15099
   PubMed Web of Science ®Google Scholar
• Kim HY, Park EJ, Joe EH, Jou I. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J Immunol. 2003;171:6072–6079
   PubMed Web of Science ®Google Scholar
• Xu YX, Pindolia KR, Janakiraman N, et al. Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells. Exp Hematol. 1997;25:413–422
   PubMed Web of Science ®Google Scholar
• Vaughan RA, Garcia-Smith R, Dorsey J, et al. Tumor necrosis factor alpha induces Warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells. Int J Cancer. 2013;133:2504–2510
   PubMed Web of Science ®Google Scholar
• Saja K, Babu MS, Karunagaran D, Sudhakaran PR. Anti-inflammatory effect of curcumin involves downregulation of MMP-9 in blood mononuclear cells. Int Immunopharmacol. 2007;7:1659–1667
   PubMed Web of Science ®Google Scholar
• Klawitter M, Quero L, Klasen J, et al. Curcuma DMSO extracts and curcumin exhibit an anti-inflammatory and anti-catabolic effect on human intervertebral disc cells, possibly by influencing TLR2 expression and JNK activity. J Inflamm (Lond). 2012;9:29
   PubMed Web of Science ®Google Scholar
• Rogers NM, Kireta S, Coates PT. Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo. Clin Exp Immunol. 2010;162:460–473
   PubMed Web of Science ®Google Scholar
• Goto R, You S, Zaitsu M, et al. Delayed anti-CD3 therapy results in depletion of alloreactive T cells and the dominance of Foxp3+ CD4+ graft infiltrating cells. Am J Transplant. 2013;13:1655–1664
   PubMed Web of Science ®Google Scholar
• Baas MC, Besancon A, Sawitzki B, et al. Intragraft mechanisms associated with the immunosuppressive versus the tolerogenic effect of CD3 antibodies in a mouse model of islet allografts. Transplant Proc. 2013;45:1895–1898
   PubMed Web of Science ®Google Scholar
• You S, Zuber J, Kuhn C, et al. Induction of allograft tolerance by monoclonal CD3 antibodies: a matter of timing. Am J Transplant. 2012;12:2909–2919
   PubMed Web of Science ®Google Scholar
• Chatenoud L, Bluestone JA. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat Rev Immunol. 2007;7:622–632
   PubMed Web of Science ®Google Scholar
• Bhagwat SP, Wright TW, Gigliotti F. Anti-CD3 antibody decreases inflammation and improves outcome in a murine model of pneumocystis pneumonia. J Immunol. 2010;184:497–502
   PubMed Web of Science ®Google Scholar
• You S, Leforban B, Garcia C, et al. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc Natl Acad Sci U S A. 2007;104:6335–6340
   PubMed Web of Science ®Google Scholar
• Chatenoud L. CD3 antibody treatment stimulates the functional capability of regulatory T cells. Novartis Found Symp. 2003;252:279–286; discussion 286–290
   PubMedGoogle Scholar
• Zhang JL, Sun DJ, Hou CM, et al. CD3 mAb treatment ameliorated the severity of the cGvHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney. Transpl Immunol. 2010;24:17–25
   PubMed Web of Science ®Google Scholar
• Sasaki N, Yamashita T, Takeda M, et al. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation. 2009;120:1996–2005
   PubMed Web of Science ®Google Scholar
• Mfarrej B, Keir M, Dada S, et al. Anti-CD3 mAb treatment cures PDL1−/−. NOD mice of diabetes but precipitates fatal myocarditis. Clin Immunol. 2011;140:47–53
   PubMed Web of Science ®Google Scholar
• Milgrom H, Huang H. Allergic disorders at a venerable age: a mini-review. Gerontology. 2014;60:99–107
   PubMed Web of Science ®Google Scholar
• Ventura MT, Gelardi M, D'Amato A, et al. Clinical and cytologic characteristics of allergic rhinitis in elderly patients. Ann Allergy Asthma Immunol. 2012;108:141–144
   PubMed Web of Science ®Google Scholar
• Knop E, Knop N. Eye-associated lymphoid tissue (EALT) is continuously spread throughout the ocular surface from the lacrimal gland to the lacrimal drainage system. Ophthalmologe. 2003;100:929–942
   PubMed Web of Science ®Google Scholar
• Knop E, Knop N. Influence of the eye-associated lymphoid tissue (EALT) on inflammatory ocular surface disease. Ocul Surf. 2005;3:S180–186
   PubMed Web of Science ®Google Scholar
• Matsuda M, Ina K, Kitamura H, et al. Demonstration and organization of duct-associated lymphoid tissue (DALT) of the main excretory duct in the monkey parotid gland. Arch Histol Cytol. 1997;60:493–502
   PubMed Web of Science ®Google Scholar
• Nair PN, Schroeder HE. Duct-associated lymphoid tissue (DALT) of minor salivary glands and mucosal immunity. Immunology. 1986;57:171–180
   PubMed Web of Science ®Google Scholar
• Kaila T, Huupponen R, Salminen L. Effects of eyelid closure and nasolacrimal duct occlusion on the systemic absorption of ocular timolol in human subjects. J Ocul Pharmacol. 1986;2:365–369
   PubMedGoogle Scholar
• Kakizaki H, Takahashi Y, Miyazaki H, Nakamura Y. Movement of internal canalicular orifice in association with blinking: direct observation after dacryocystorhinostomy. Am J Ophthalmol. 2013;156:1051–1055 e1051
   PubMed Web of Science ®Google Scholar
• McLean CJ, Rose GE. Postherpetic lacrimal obstruction. Ophthalmology. 2000;107:496–499
   PubMed Web of Science ®Google Scholar
• Thompson CJ. Review of the diagnosis and management of acquired nasolacrimal duct obstruction. Optometry. 2001;72:103–111
   PubMedGoogle Scholar
• Gamache DA, Dimitrijevich SD, Weimer LK, et al. Secretion of proinflammatory cytokines by human conjunctival epithelial cells. Ocul Immunol Inflamm. 1997;5:117–128
   PubMed Web of Science ®Google Scholar
• Yanni JM, Miller ST, Gamache DA, et al. Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells. Ann Allergy Asthma Immunol. 1997;79:541–545
   PubMed Web of Science ®Google Scholar
• Chodosh J, Kennedy RC. The conjunctival lymphoid follicle in mucosal immunology. DNA Cell Biol. 2002;21:421–433
   PubMed Web of Science ®Google Scholar
• Hamrah P, Dana MR. Corneal antigen–presenting cells. Chem Immunol Allergy. 2007;92:58–70
   PubMedGoogle Scholar
• Hamrah P, Yamagami S, Liu Y, et al. Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival. Invest Ophthalmol Vis Sci. 2007;48:1228–1236
   PubMed Web of Science ®Google Scholar
• Dana R. Corneal antigen presentation: molecular regulation and functional implications. Ocul Surf. 2005;3:S169–S172
   PubMed Web of Science ®Google Scholar
• Qian Y, Dana MR. Molecular mechanisms of immunity in corneal allotransplantation and xenotransplantation. Expert Rev Mol Med. 2001;2001:1–21
   Google Scholar
• Hamrah P, Chen L, Zhang Q, Dana MR. Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am J Pathol. 2003;163:57–68
   PubMed Web of Science ®Google Scholar
• Qian L, Xie J, Rose CM, et al. Altered traffic to the lysosome in an ex vivo lacrimal acinar cell model for chronic muscarinic receptor stimulation. Exp Eye Res. 2004;79:665–675
   PubMed Web of Science ®Google Scholar
• Chen W, Chan AS, Dawson AJ, et al. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function. Biol Blood Marrow Transplant. 2005;11:23–34
   PubMed Web of Science ®Google Scholar
• Bauer D, Schmitz A, Van Rooijen N, et al. Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection. Immunology. 2002;107:118–128
   PubMed Web of Science ®Google Scholar
• Nesburn AB, Bettahi I, Dasgupta G, et al. Functional Foxp3+ CD4+CD25(Bright+) “natural” regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection. J Virol. 2007;81:6911–6919
   Web of Science ®Google Scholar
• Zhang X, Schaumburg CS, Coursey TG, et al. CD8(+) cells regulate the T helper-17 response in an experimental murine model of Sjögren syndrome. Mucosal Immunol. 2014;7:417–427
   PubMed Web of Science ®Google Scholar
• Niederkorn JY, Stern ME, Pflugfelder SC, et al. Desiccating stress induces T cell-mediated Sjögren's syndrome-like lacrimal keratoconjunctivitis. J Immunol. 2006;176:3950–3957
   PubMed Web of Science ®Google Scholar
• Lagranderie M, Abolhassani M, Vanoirbeek JA, et al. Mycobacterium bovis bacillus Calmette-Guerin killed by extended freeze-drying targets plasmacytoid dendritic cells to regulate lung inflammation. J Immunol. 2010;184:1062–1070
   PubMed Web of Science ®Google Scholar
• Schaumburg CS, Siemasko KF, De Paiva CS, et al. Ocular surface APCs are necessary for autoreactive T-cell-mediated experimental autoimmune lacrimal keratoconjunctivitis. J Immunol. 2011;187:3653–3662
   PubMed Web of Science ®Google Scholar
• Zhang X, Volpe EA, Gandhi NB, et al. NK cells promote Th-17 mediated corneal barrier disruption in dry eye. PLoS One. 2012;7:e36822
   PubMed Web of Science ®Google Scholar
• De Paiva CS, Chotikavanich S, Pangelinan SB, et al. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol. 2009;2:243–253
   PubMed Web of Science ®Google Scholar
• De Paiva CS, Villarreal AL, Corrales RM, et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci. 2007;48:2553–2560
   PubMed Web of Science ®Google Scholar
• Ridley Lathers DM, Gill RF, Montgomery PC. Inductive pathways leading to rat tear IgA antibody responses. Invest Ophthalmol Vis Sci. 1998;39:1005–1011
   PubMed Web of Science ®Google Scholar
• Barabino S, Chen W, Dana MR. Tear film and ocular surface tests in animal models of dry eye: uses and limitations. Exp Eye Res. 2004;79:613–621
   PubMed Web of Science ®Google Scholar
• Pockley AG, Montgomery PC. In vivo adjuvant effect of interleukins 5 and 6 on rat tear IgA antibody responses. Immunology. 1991;73:19–23
   PubMed Web of Science ®Google Scholar
• Hessel T, Dhital SP, Plank R, Dean D. Immune response to chlamydial 60-kilodalton heat shock protein in tears from Nepali trachoma patients. Infect Immun. 2001;69:4996–5000
   PubMed Web of Science ®Google Scholar
• Meek B, Klaren VN, van Haeringen NJ, et al. IgA antibodies to Toxoplasma gondii in human tears. Invest Ophthalmol Vis Sci. 2000;41:2584–2590
   PubMed Web of Science ®Google Scholar
• Saitoh-Inagawa W, Hiroi T, Yanagita M, et al. Unique characteristics of lacrimal glands as a part of mucosal immune network: high frequency of IgA-committed B-1 cells and NK1.1+ alphabeta T cells. Invest Ophthalmol Vis Sci. 2000;41:138–144
   PubMed Web of Science ®Google Scholar
• Montgomery PC, Majumdar AS, Skandera CA, Rockey JH. The effect of immunization route and sequence of stimulation on the induction of IgA antibodies in tears. Curr Eye Res. 1984;3:861–865
   PubMed Web of Science ®Google Scholar
• Gill RF, Montgomery PC. Enhancement of rat tear IgA antibody responses following intranasal immunization with antigen and CpG ODN. Curr Eye Res. 2002;24:228–233
   PubMed Web of Science ®Google Scholar
• Gill RF, Pirockinaite G, O'Sullivan NL, Montgomery PC. Nasal-associated lymphoid tissue is not an absolute requirement for the induction of rat tear IgA antibody responses. Curr Eye Res. 2010;35:1–8
   PubMed Web of Science ®Google Scholar
• Carr RM, Lolachi CM, Albaran RG, et al. Nasal-associated lymphoid tissue is an inductive site for rat tear IgA antibody responses. Immunol Invest. 1996;25:387–396
   PubMed Web of Science ®Google Scholar
• Peppard JV, Montgomery PC. Studies on the origin and composition of IgA in rat tears. Immunology. 1987;62:193–198
   PubMed Web of Science ®Google Scholar
• Peppard JV, Mann RV, Montgomery PC. Antibody production in rats following ocular-topical or gastrointestinal immunization: kinetics of local and systemic antibody production. Curr Eye Res. 1988;7:471–481
   PubMed Web of Science ®Google Scholar
• Aghayan-Ugurluoglu R, Ball T, Vrtala S, et al. Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens. J Allergy Clin Immunol. 2000;105:803–813
   PubMed Web of Science ®Google Scholar
• German AJ, Hall EJ, Day MJ. Measurement of IgG, IgM and IgA concentrations in canine serum, saliva, tears and bile. Vet Immunol Immunopathol. 1998;64:107–121
   PubMed Web of Science ®Google Scholar
• Knop E, Knop N. Lacrimal drainage-associated lymphoid tissue (LDALT): a part of the human mucosal immune system. Invest Ophthalmol Vis Sci. 2001;42:566–574
   PubMed Web of Science ®Google Scholar
• Lan JX, Willcox MD, Jackson GD, Thakur A. Effect of tear secretory IgA on chemotaxis of polymorphonuclear leucocytes. Aust N Z J Ophthalmol. 1998;26 (Suppl 1):S36–S39
   PubMedGoogle Scholar
• Nesburn AB, Burke RL, Ghiasi H, et al. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits. Virology. 1998;252:200–209
   PubMed Web of Science ®Google Scholar
• Phillips TE, Sharp J, Rodgers K, Liu H. M cell-targeted ocular immunization: effect on immunoglobulins in tears, feces, and serum. Invest Ophthalmol Vis Sci. 2010;51:1533–1539
   PubMed Web of Science ®Google Scholar
• Paulsen AJ, Cruickshanks KJ, Fischer ME, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157:799–806
   PubMed Web of Science ®Google Scholar
• Paulsen F. Functional anatomy and immunological interactions of ocular surface and adnexa. Dev Ophthalmol. 2008;41:21–35
   PubMedGoogle Scholar
• Knop N, Knop E. Conjunctiva-associated lymphoid tissue in the human eye. Invest Ophthalmol Vis Sci. 2000;41:1270–1279
   PubMed Web of Science ®Google Scholar
• Liu SH, Tagawa Y, Prendergast RA, et al. Secretory component of IgA: a marker for differentiation of ocular epithelium. Invest Ophthalmol Vis Sci. 1981;20:100–109
   PubMed Web of Science ®Google Scholar
• Mircheff AK, Wang Y, Jean Mde S, et al. Mucosal immunity and self-tolerance in the ocular surface system. Ocul Surf. 2005;3:182–192
   PubMed Web of Science ®Google Scholar
• Eksteen B, Miles A, Curbishley SM, et al. Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. J Immunol. 2006;177:593–603
   PubMed Web of Science ®Google Scholar
• Lan RY, Mackay IR, Gershwin ME. Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border. J Autoimmun. 2007;29:272–280
   PubMed Web of Science ®Google Scholar
• Tsuji NM. Antigen-specific CD4(+) regulatory T cells in the intestine. Inflamm Allergy Drug Targets. 2006;5:191–201
   PubMedGoogle Scholar
• Design and conduct of clinical trials: report of the Clinical Trials Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:153–162
   Google Scholar
• Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:108–152
   Google Scholar
• The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:93–107
   Google Scholar
• Bouchard CS, Lasky JB, Cundiff JE, Smith BS. Ocular surface upregulation of intercellular adhesive molecule-1 (ICAM-1) by local interferon-gamma (IFN-gamma) in the rat. Curr Eye Res. 1996;15:203–208
   PubMed Web of Science ®Google Scholar
• Dasgupta G, Nesburn AB, Wechsler SL, BenMohamed L. Developing an asymptomatic mucosal herpes vaccine: the present and the future. Future Microbiol. 2010;5:1–4
   PubMed Web of Science ®Google Scholar
• Nesburn AB, Burke RL, Ghiasi H, et al. A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal disease. Invest Ophthalmol Vis Sci. 1998;39:1163–1170
   PubMed Web of Science ®Google Scholar
• Nesburn AB, Slanina S, Burke RL, et al. Local periocular vaccination protects against eye disease more effectively than systemic vaccination following primary ocular herpes simplex virus infection in rabbits. J Virol. 1998;72:7715–7721
   PubMed Web of Science ®Google Scholar
• Bettahi I, Nesburn AB, Yoon S, et al. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines. Invest Ophthalmol Vis Sci. 2007;48:4643–4653
   PubMed Web of Science ®Google Scholar
• Kuper CF, Koornstra PJ, Hameleers DM, et al. The role of nasopharyngeal lymphoid tissue. Immunol Today. 1992;13:219–224
   PubMedGoogle Scholar
• Dasgupta G, Chentoufi AA, Nesburn AB, et al. New concepts in herpes simplex virus vaccine development: notes from the battlefield. Expert Rev Vaccines. 2009;8:1023–1035
   PubMed Web of Science ®Google Scholar
• Nochi T, Kiyono H. Innate immunity in the mucosal immune system. Curr Pharm Des. 2006;12:4203–4213
   PubMed Web of Science ®Google Scholar
• Takahashi I, Nochi T, Yuki Y, Kiyono H. New horizon of mucosal immunity and vaccines. Curr Opin Immunol. 2009;21:352–358
   PubMed Web of Science ®Google Scholar